Evidence map›Paper›PMID 41083920›Full record

ArticleJournal of inherited metabolic disease2025

Myo-Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study.

Eva Niess, Fabian Niess, Wolfgang Bogner, Alena Svatkova, Marion Herle, Lisa Laußner, Lukas Hingerl, Bernhard Strasser, Maximilian Pichler, Vassiliki Konstantopoulou and 6 more

Abstract read
In one paragraph

Article in Journal of inherited metabolic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Eva NiessHigh Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-9956-1470
Fabian NiessHigh Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-1235-7595
Wolfgang BognerHigh Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-0130-3463
Alena SvatkovaDanish Research Centre for Magnetic Resonance, Department of Radiology and Nuclear Medicine, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
Marion HerleDivision of Pediatric Pulmonology, Allergology and Endocrinology, Austrian Newborn Screening, Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-0702-4374
Lisa LaußnerDivision of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Lukas HingerlHigh Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Bernhard StrasserHigh Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Maximilian PichlerChristian Doppler Laboratory for MR Imaging Biomarkers (BIOMAK), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0009-0005-3633-1682
Vassiliki KonstantopoulouDepartment of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Miriam Hufgard-LeitnerDivision of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Dominic BuchingerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Ivan MilenkovicDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Alexandra Kautzky-WillerDivision of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-3520-4105
Thomas StulnigDivision of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Thomas SchererDivision of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Funding

Austrian Science Fund COE14Austrian Science Fund I6037Austrian Science Fund KLI1106Austrian Science Fund P36328Galactosemia FoundationH2020 Marie Skłodowska-Curie Actions 794986
6 · The paper itself

Abstract

Classic galactosemia is a rare metabolic disorder resulting from galactose-1-phosphate uridylyltransferase deficiency, which disrupts normal galactose metabolism, leading to toxic accumulation of galactose-1-phosphate and galactitol. Despite early dietary intervention, patients remain at risk for long-term neurological impairments, including cognitive deficits, motor speech disorders, and psychiatric conditions. The mechanisms driving these persistent abnormalities remain unclear. This study investigated brain metabolic and structural alterations in adults with classic galactosemia using advanced multiparametric MRI. Six patients (3 males, 3 females; mean age 34.0 ± 7.3 years) adhering to lifelong galactose-restricted diets and six age- and sex-matched controls underwent 3T and 7T MRI, including T1-weighted imaging, pseudo-continuous arterial spin labeling, and high-resolution MR spectroscopic imaging. Patients exhibited significantly lower myo-inositol (mIns) concentrations in cerebellum (p = 0.007), putamen (p = 0.023), and cerebral white matter (p = 0.001), reflecting a chronic mIns deficiency despite dietary management. Structural analyses revealed reduced volumes of white matter (p < 0.001), bilateral putamen (p < 0.038), and left thalamus (p = 0.044); alongside increased cortical thickness and reduced cortical surface area, indicating abnormal cortical maturation, particularly in regions associated with motor and cognitive processing. Additionally, cerebral blood flow was elevated in emotion-processing regions, including bilateral amygdala (p < 0.022) and thalamus (p < 0.038). These preliminary findings highlight persistent neurological alterations in classic galactosemia despite dietary management and suggest that chronic mIns deficiency may contribute to the pathophysiology. They underscore the need for larger, longitudinal studies to confirm these results, investigate potential correlations with clinical severity and biochemical markers, and explore therapeutic strategies aimed at modulating mIns metabolism.

Indexed as

BrainCerebrovascular CirculationGalactosemiasInositolAdultCase-Control StudiesFemaleGalactoseHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleYoung AdultGalactoseInositolcerebral blood flowclassic galactosemiacortical thicknessMR spectroscopic imagingMR spectroscopymyo‐inositol

Identifiers

PMID41083920
PMCPMC12518697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.